Cargando…
Comparative transcriptomic analysis reveals the oncogenic fusion protein PAX3-FOXO1 globally alters mRNA and miRNA to enhance myoblast invasion
Rhabdomyosarcoma, one of the most common childhood sarcomas, is comprised of two main subtypes, embryonal and alveolar (ARMS). ARMS, the more aggressive subtype, is primarily characterized by the t(2;13)(p35;p14) chromosomal translocation, which fuses two transcription factors, PAX3 and FOXO1 to gen...
Autores principales: | Loupe, J M, Miller, P J, Bonner, B P, Maggi, E C, Vijayaraghavan, J, Crabtree, J S, Taylor, C M, Zabaleta, J, Hollenbach, A D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972903/ https://www.ncbi.nlm.nih.gov/pubmed/27454080 http://dx.doi.org/10.1038/oncsis.2016.53 |
Ejemplares similares
-
Acquisition of an oncogenic fusion protein is sufficient to globally alter the landscape of miRNA expression to inhibit myogenic differentiation
por: Loupe, Jacob M., et al.
Publicado: (2017) -
Acquisition of an oncogenic fusion protein serves as an initial driving mutation by inducing aneuploidy and overriding proliferative defects
por: Loupe, Jacob M., et al.
Publicado: (2016) -
Inhibiting phosphorylation of the oncogenic PAX3-FOXO1 reduces alveolar rhabdomyosarcoma phenotypes identifying novel therapy options
por: Loupe, J M, et al.
Publicado: (2015) -
The PAX3-FOXO1 oncogene alters exosome miRNA content and leads to paracrine effects mediated by exosomal miR-486
por: Ghamloush, Farah, et al.
Publicado: (2019) -
FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma.
por: Milewski, David, et al.
Publicado: (2021)